BioBank Data Exchange turns a plain-language research question into a governed, consent-aware, AI-ready cohort — curated on demand across multi-institutional biospecimen data that was never accessible before. Independent by design; intelligent by architecture.
No existing platform simultaneously provides what BDE delivers. We occupy a structurally uncontested position in the biomedical data ecosystem.
Upstream suppliers — non-commercial, long approval cycles, no cross-institution discovery. BDE: Governance partner, not competitor.
Closed ecosystems, non-neutral incentives, no multi-biobank federation. BDE: Structurally incompatible — we are independent.
Solve how data is accessed, not which data or under what conditions. BDE: Complements, not competitors.
Lack biospecimen provenance, consent hooks, and clinical depth. BDE: Biologically and operationally superior.
BDE’s curation intelligence sits between a researcher’s request and the federated data network — translating intent into a governed, de-identified, feasibility-checked dataset. AI does the assembly; independent governance sets the rules it cannot break.
A researcher states the cohort in plain language — indication, line of therapy, biospecimen, follow-up window.
Language models map free-text criteria to standardized concept sets — SNOMED, RxNorm, LOINC — over the OMOP vocabulary.
An agent runs federated counts across institutions, tuning criteria to hit target N and surfacing every trade-off.
Consent scope enforced, de-identification and re-identification risk scored, then delivered in OMOP, FHIR, or Parquet.
Describe the dataset you need the way you’d brief a colleague — no SQL, no data dictionary spelunking, no weeks of back-and-forth with a data team. Intent in, specification out.
Before anything is committed, an agent reports what is actually available across the network — and how relaxing a single criterion changes feasible N. Answers before commitments.
Consent scope, IRB conditions, and de-identification are deterministic guardrails wrapped around every model action — and written to an immutable audit trail. Intelligence inside the rules.
Investors and partners can run the live Cohort Curator — turning a plain-language request into a governed, feasibility-checked cohort — inside the secure portal.
Open the Cohort Curator →Decades of biospecimen data have accumulated in siloed institutions. The technology to connect them securely now exists. What was missing was independent market infrastructure — governed, consent-aware, AI-native, and economically aligned for all participants.
Describe the cohort you need in plain language; BDE assembles a feasible, consent-cleared, de-identified dataset — cutting discovery timelines from months to days.
A commercial pathway that respects consent frameworks and governance mandates — turning archived collections into sustainable research infrastructure.
Federated, consent-aware discovery. Standards-based interoperability (OMOP, FHIR, GA4GH). Independent governance that no single participant controls.
Frontier AI is now bottlenecked by biologically grounded data — and the agentic tooling to curate it on demand has arrived. Privacy tech is mature. Biobanks need sustainable models. The moment is now.
Whether you’re a biobank, pharma organization, research institution, or potential partner — we’d like to hear from you.
Full access to BDE’s business plan, competitive analysis, market sizing, strategic memos, and live data platform demo — for authorized investors and partners only.
Choose how you'd like to proceed